SCHEMBL6327914

SCHEMBL6327914

O=C(CCc1nc(-c2ccccc2)no1)N1CCCN(Cc2n[nH]c(=O)c3ccccc23)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.56
▸ ALDH1A1 P00352 3/20 0.56
▸ TSHR P16473 2/20 0.56
▸ HTT P42858 2/20 0.56
▸ LMNA P02545 3/20 0.52
▸ HPGD P15428 2/20 0.52
▸ PARP1 P09874 6/20 0.49
▸ POLB P06746 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ ATM Q13315 1/20 0.45
▸ USP2 O75604 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ ROCK2 O75116 1/20 0.44
▸ ROCK1 Q13464 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ CYP2D6 P10635 1/20 0.43
▸ KCNH2 Q12809 1/20 0.43
▸ TNKS O95271 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6324019 0.97 MAPT (0.59) MAPTALDH1A1TSHRHTTLMNA
SCHEMBL6334598 0.94 LMNA (0.62) MAPTALDH1A1TSHRHTTLMNA
SCHEMBL6328130 0.91 TSHR (0.68) MAPTALDH1A1TSHRHTTLMNA
SCHEMBL6326044 0.90 MAPT (0.56) MAPTALDH1A1TSHRHTTLMNA
SCHEMBL6324067 0.88 MAPT (0.72) MAPTALDH1A1TSHRHTTLMNA
SCHEMBL6332641 0.86 PARP1 (0.47) MAPTALDH1A1TSHRHTTLMNA
SCHEMBL6331273 0.83 MAPT (0.48) MAPTALDH1A1TSHRHTTLMNA
SCHEMBL6328650 0.77 PARP1 (0.57) PARP1KMT2AROCK2ROCK1SMN1; SMN2
SCHEMBL6325619 0.76 CYP1A2 (0.58) MAPTALDH1A1TSHRHTTLMNA
SCHEMBL6328504 0.71 HCRTR1 (0.46) MAPTALDH1A1TSHRHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6924284-B2 PARP inhibitors ICOS CORPORATION (US) 2005-08-02 — — US disclosed
Send feedback